## FDX: FedEx Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.4% below STRENGTH zone (3.0-6.0%); PEG 1.28 fails VALUE criteria (<1.0); RSI 75 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (75).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($279.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 4, Bearish: 1)

**1. Jim Cramer Loves FedEx (FDX) CEO**
- Source: Finviz | 20251222T173854 | Bullish | Relevance: 100%
- Jim Cramer has expressed optimism about FedEx Corporation (FDX) and its CEO, Raj, commending his leadership and the company's turnaround efforts. Analysts from Stifel and BMO Capital have also reiterated positive ratings and raised price targets for FDX shares after the company beat earnings estimates. Cramer's prediction about a strong performance for FedEx was validated by their recent earnings report.

**2. FedEx (NYSE:FDX) Given New $305.00 Price Target at Raymond James Financial**
- Source: MarketBeat | 20251222T145127 | Bullish | Relevance: 100%
- Raymond James Financial has set a new price target of $305.00 for FedEx (NYSE:FDX), maintaining an "outperform" rating, indicating a 5.28% potential upside. This adjustment follows FedEx's strong Q3 earnings report, which surpassed analyst expectations for both EPS and revenue. While analyst opinions are varied, with a consensus "Hold" rating and an average price target of $299.12, institutional investors hold a significant 84.47% stake in the company.

**3. Jim Cramer Applauds FedEx for a Strong Quarter**
- Source: Finviz | 20251221T102600 | Bullish | Relevance: 100%
- Jim Cramer praised FedEx's latest quarterly results, highlighting higher-than-expected revenues and an earnings beat. He noted the company's successful cost-cutting efforts and optimized delivery network, leading to a raised full-year forecast. Cramer also believes FedEx is well-positioned for growth, especially with the surge in e-commerce and its impending freight division spin-off.

**4. FedEx Data Breach Exposes Sensitive Protected Health Information (PHI)**
- Source: Claim Depot | 20251222T160032 | Bearish | Relevance: 100%
- FedEx Corporation Group Health Plan disclosed a cybersecurity incident on December 1, 2025, potentially compromising the personally identifiable information (PII) and protected health information (PHI) of at least 1,066 individuals. The breach affects current and former employees covered by the group health plan, involving details such as names, Social Security numbers, medical plan information, and health claims. FedEx has notified authorities and is expected to contact affected individuals with details on mitigation steps.

**5. Bartlett & CO. Wealth Management LLC Sells 8,400 Shares of FedEx Corporation $FDX**
- Source: MarketBeat | 20251220T090752 | Bullish | Relevance: 100%
- Bartlett & CO. Wealth Management LLC reduced its stake in FedEx Corporation by 13.7%, selling 8,400 shares and leaving them with 52,935 shares valued at $12.54 million. This move follows FedEx reporting stronger-than-expected quarterly earnings of $4.82 EPS and revenue of $23.47 billion, which led to multiple analyst price target increases and current "Moderate Buy" rating. The company also announced a quarterly dividend of $1.45 per share, with an ex-dividend date of December 15th.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 15, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Citigroup | $327 | $310 | +5% |
| 2025-12-19 | Truist Securiti | $330 | $285 | +16% |
| 2025-12-19 | Morgan Stanley | $210 | $200 | +5% |
| 2025-12-19 | BMO Capital | $290 | $265 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Citigroup | main | Buy |
| 2025-12-19 | Truist Securiti | main | Buy |
| 2025-12-19 | Morgan Stanley | main | Underweight |
| 2025-12-19 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.49M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.9% (+13.2%)
- Blackrock Inc.: 7.2% (-2.5%)
- Dodge & Cox Inc.: 6.9% (+12.0%)
- Primecap Management : 4.0% (-6.4%)
- State Street Corpora: 3.9% (-2.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 15 raises (avg +8%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.28 suggests fair value with growth premium. Forward P/E 13.8x attractive for 15% earnings growth. Balance sheet: $1.2B free cash flow. Analyst sentiment positive (15 raises, avg +8%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $69.1B |
| Beta | 1.33 |
| 52W Range | $194.30 - $292.82 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.28 |
| Forward P/E | 13.8 |
| Current P/E | 15.9 |
| YoY Growth | 15.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.7% over 5 days). Below STRENGTH zone by 0.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 75, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.40% (CS: 86) | Neutral |
| RSI_14 | 75.3 | Overbought |
| MACD Histogram | 0.44 | Bullish |
| vs SMA20 | 1.050x | Above |
| vs SMA50 | 1.114x | Above |
| vs SMA200 | 1.238x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $292.65
- **Stop Loss:** $279.59 (4.5% risk)
- **Target:** $305.71 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $19,900.20
- **Portfolio %:** 19.90%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.11 | $4.82 | +17.2% |
| 2025Q3 | $3.61 | $3.83 | +6.0% |
| 2025Q2 | $5.80 | $6.07 | +4.6% |
| 2025Q1 | $4.62 | $4.51 | -2.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*